IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $29,000 | +11.5% | 1,499 | -6.3% | 0.01% | +9.1% |
| Q4 2017 | $26,000 | -51.9% | 1,599 | -40.3% | 0.01% | -62.1% |
| Q3 2017 | $54,000 | +134.8% | 2,677 | +87.3% | 0.03% | +123.1% |
| Q2 2017 | $23,000 | – | 1,429 | +5616.0% | 0.01% | – |
| Q1 2017 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 25 | -71.6% | 0.00% | -100.0% |
| Q3 2016 | $2,000 | 0.0% | 88 | -12.9% | 0.00% | 0.0% |
| Q2 2016 | $2,000 | -33.3% | 101 | -3.8% | 0.00% | -50.0% |
| Q1 2016 | $3,000 | -83.3% | 105 | -75.9% | 0.00% | -81.8% |
| Q4 2015 | $18,000 | – | 436 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |